REFERENCES
- Maroszynska I, Fiedor P. Leukocytes and endothelium interaction as rate limiting step in the inflammatory response and a key factor in the ischemia–reperfusion injury. Ann Transplant 2000; 5: 5–11, [PUBMED], [INFOTRIEVE], [CSA]
- Krupinski J, Kaluza J, Kumar P, Kumar S, Wang J M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25: 1794–1798, [PUBMED], [INFOTRIEVE]
- Lin T N, Wang C K, Cheung W M, Hsu C Y. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia–reperfusion. J Cereb Blood Flow Metab 2000; 20: 387–395, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lin T N, Nian G M, Chen S F, Cheung W M, Chang C, Lin W C, Hsu C Y. Induction of Tie-1 and Tie-2 receptor protein expression after cerebral ischemia–reperfusion. J Cereb Blood Flow Metab 2001; 21: 690–701, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Buschmann I, Heil M, Jost M, Schaper W. Influence of inflammatory cytokines on arteriogenesis. Microcirculation 2003; 10: 371–379, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kelly B D, Hackett S F, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro P A, Semenza G L. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074–1081, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Barleon B, Sozzani S, Zhou D, Weich H A, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336–3343, [PUBMED], [INFOTRIEVE], [CSA]
- Ancelin M, Chollet-Martin S, Herve M A, Legrand C, Benna J E, Perrot-Applanat M. Vascular endothelial growth factor VEGF189 induces human neutrophil chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab Invest 2004; 84: 502–512, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thurston G, Suri C, Smith K, McClain J, Sato T N, Yancopoulos G D, McDonald D M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511–2514, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Detmar M, Brown L F, Schon M P, Elicker B M, Velasco P, Richard L, Fukumura D, Monsky W, Claffey K P, Jain R K. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 1998; 111: 1–6, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Yancopoulos G D, Davis S, Gale N W, Rudge J S, Wiegand S J, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kim I, Moon S O, Park S K, Chae S W, Koh G Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001; 89: 477–479, [PUBMED], [INFOTRIEVE]
- Maisonpierre P C, Suri C, Jones P F, Bartunkova S, Wiegand S J, Radziejewski C, Compton D, McClain J, Aldrich T H, Papadopoulos N, Daly T J, Davis S, Sato T N, Yancopoulos G D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55–60, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Papapetropoulos A, Garcia-Cardena G, Dengler T J, Maisonpierre P C, Yancopoulos G D, Sessa W C. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 1999; 79: 213–223, [PUBMED], [INFOTRIEVE], [CSA]
- Cullen V C, Mackarel A J, Hislip S J, O'Connor C M, Keenan A K. Investigation of vascular endothelial growth factor effects on pulmonary endothelial monolayer permeability and neutrophil transmigration. Gen Pharmacol 2000; 35: 149–157, [PUBMED], [INFOTRIEVE], [CSA]
- Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 2003; 139: 329–336, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Witzenbichler B, Maisonpierre P C, Jones P, Yancopoulos G D, Isner J M. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 1998; 273: 18514–18521, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tsigkos S, Koutsilieris M, Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Invest Drugs 2003; 12: 933–941, [CSA], [CROSSREF]
- Lemieux C, Maliba R, Favier J, Theoret J F, Merhi Y, Sirois M G. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2004; 105: 1523–1530, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Feistritzer C, Mosheimer B A, Sturn D H, Bijuklic K, Patsch J R, Wiedermann C J. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 2004; 114: 1077–1084, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shalaby F, Rossant J, Yamaguchi T P, Gertsenstein M, Wu X F, Breitman M L, Schuh A C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62–66, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–439, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea K S, Powell-Braxton L, Hillan K J, Moore M W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–442, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dumont D J, Gradwohl G, Fong G H, Puri M C, Gertsenstein M, Auerbach A, Breitman M L. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8: 1897–1909, [PUBMED], [INFOTRIEVE]
- Sato T N, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995; 376: 70–74, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Davis S, Aldrich T H, Jones P F, Acheson A, Compton D L, Jain V, Ryan T E, Bruno J, Radziejewski C, Maisonpierre P C, Yancopoulos G D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161–1169, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Suri C, Jones P F, Patan S, Bartunkova S, Maisonpierre P C, Davis S, Sato T N, Yancopoulos G D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171–1180, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1–30, [PUBMED], [INFOTRIEVE], [CSA]
- Dvorak H F, Nagy J A, Feng D, Brown L F, Dvorak A M. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 1999; 237: 97–132, [PUBMED], [INFOTRIEVE], [CSA]
- Larcher F, Murillas R, Bolontrade M, Conti C J, Jorcano J L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 1998; 17: 303–311, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Thurston G, Rudge J S, Ioffe E, Zhou H, Ross L, Croll S D, Glazer N, Holash J, McDonald D M, Yancopoulos G D. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6: 460–463, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sato A, Iwama A, Takakura N, Nishio H, Yancopoulos G D, Suda T. Characterization of TEK receptor tyrosine kinase and its ligands, angiopoietins, in human hematopoietic progenitor cells. Int Immunol 1998; 10: 1217–1227, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brown M T, Cooper J A. Regulation, substrates and functions of src. Biochim Biophys Acta 1996; 1287: 121–149, [PUBMED], [INFOTRIEVE]
- Thomas S M, Brugge J S. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997; 13: 513–609, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ramdas L, McMurray J S, Budde R J. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability. Cancer Res 1994; 54: 867–869, [PUBMED], [INFOTRIEVE]
- Church J G, Buick R N. G-protein-mediated epidermal growth factor signal transduction in a human breast cancer cell line: evidence for two intracellular pathways distinguishable by pertussis toxin. J Biol Chem 1988; 263: 4242–4246, [PUBMED], [INFOTRIEVE]
- Howe P H, Cunningham M R, Leof E B. Inhibition of mink lung epithelial cell proliferation by transforming growth factor-beta is coupled through a pertussis-toxin-sensitive substrate. Biochem J 1990; 266: 537–543, [PUBMED], [INFOTRIEVE], [CSA]
- Cambien B, Pomeranz M, Millet M A, Rossi B, Schmid-Alliana A. Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 2001; 97: 359–366, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]